Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

We recently compiled a list of the 8 Most Oversold Large Cap Stocks to Buy. Stryker Corporation (NYSE:SYK) is one of the most oversold stocks to invest in.

TheFly reported on May 4 that SYK saw its valuation outlook revised as Truist reduced the price target to $330 from $380 while maintaining a Hold rating on the stock. The adjustment followed updates to the firm’s financial model after the company’s first quarter results. The revision also reflected disruptions from a cyber-related incident in the first quarter, which affected the timing and flow of earnings. Additionally, the lowered target incorporated broader valuation pressure, with reduced multiples across large-cap medical technology peers contributing to the updated outlook for the stock.

Is Stryker Corporation (SYK) Under Pressure? Truist Lowers Outlook but Keeps Hold Rating

Moreover, previously, on April 30, Stryker Corporation (NYSE:SYK) reaffirmed its fiscal 2026 outlook, keeping adjusted earnings per share guidance in the range of $14.90 to $15.10, slightly above consensus expectations. The company also maintained its projection for organic net sales growth between 8.0% and 9.5%, supported by modestly positive pricing trends. Management noted that foreign exchange is expected to provide a slight tailwind to both revenue and adjusted earnings per share, assuming current currency levels persist, indicating stable operational expectations for the year ahead.

Stryker Corporation (NYSE:SYK) is a global medical technology company based in Portage. It develops products in orthopaedics, surgical equipment, and neurotechnology, serving patients worldwide with innovative healthcare solutions.

While we acknowledge the risk and potential of SYK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SYK and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best Cancer Stocks to Buy for the Long Term and 10 Most Popular Stocks on Robinhood in 2026.

Disclosure: None. Follow Insider Monkey on Google News.